DELJEAN BUENAVENTURA: Open Payments
NPI 1174993612 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,528 in 81 payments from 28 companies in 2025. Trend: 2023 $917 · 2024 $1,649 · 2025 $3,528
Food & beverage: $2,864Education: $464Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $400 |
| Novo Nordisk Inc | 3 | $318 |
| AstraZeneca Pharmaceuticals LP | 6 | $269 |
| Astellas Pharma US Inc | 6 | $248 |
| Actelion Pharmaceuticals US, Inc. | 7 | $242 |
| Grifols USA, LLC | 5 | $234 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $200 |
| Verona Pharma, Inc. | 3 | $169 |
| United Therapeutics Corporation | 5 | $157 |
| Aimmune Therapeutics, Inc. | 2 | $157 |
Products named: DUPIXENT, Prolastin-C Liquid, OFEV, Ozempic, Adempas, OPSUMIT, Ohtuvayre, AIRSUPRA.
Industry payments across AZ — which companies pay providers there.
